BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37099400)

  • 1. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
    Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
    Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
    Chen S; Rodewald LE; Du AH; Tang S
    Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.
    Jiang M; Chen S; Yan X; Ying X; Tang S
    Infect Dis Poverty; 2023 Dec; 12(1):114. PubMed ID: 38062480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of non-National Immunization Program vaccination intentions in rural areas of China.
    Wang X; Fan Y; Wang W
    BMC Public Health; 2023 Aug; 23(1):1485. PubMed ID: 37542236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
    Jiang H; Wei C
    Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.
    Rodewald LE
    Infect Dis Poverty; 2023 Oct; 12(1):96. PubMed ID: 37845759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an indicator framework for vaccine inclusion in public health programs: A Delphi-entropy method study.
    Wang Q; Dai P; Jia M; Jiang M; Li J; Yang W; Feng L
    Hum Vaccin Immunother; 2023 Dec; 19(3):2272539. PubMed ID: 37905961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action.
    Li J; Chen S; Asturias E; Tang S; Cui F
    Infect Dis Poverty; 2024 Feb; 13(1):12. PubMed ID: 38297394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination strategies in developing countries.
    Poore P
    Vaccine; 1988 Oct; 6(5):393-8. PubMed ID: 3057759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking immunization programs through the life course approach.
    Balsells E; Ghiselli M; Hommes C; Nascimento Lins de Oliveira B; Rosado-Valenzuela AL; Vega E
    Front Public Health; 2024; 12():1355384. PubMed ID: 38487192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building and sustaining public and political commitment to the value of vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2).
    Olayinka F; Sauer M; Menning L; Summers D; Wonodi C; Mackay S; MacDonald NE; Peter Figueroa J; Andriamitantsoa B; Bonsu G; Haldar P; Lindstrand A; Shimp L;
    Vaccine; 2022 Dec; ():. PubMed ID: 36528448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.
    Teresa Aguado M; Barratt J; Beard JR; Blomberg BB; Chen WH; Hickling J; Hyde TB; Jit M; Jones R; Poland GA; Friede M; Ortiz JR
    Vaccine; 2018 Feb; 36(7):921-931. PubMed ID: 29336923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vaccination status of children with special health care needs in Suzhou, China, 2020-2022: A retrospective survey study.
    Luan L; Zhang Z; Xu J; Kong X; Yu J; Hu R; Liu N; Wang T; Zhang J; Wang J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2254965. PubMed ID: 37697437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Introduction to the Japanese Immunization Program: Past, Present, and Future Perspectives.
    Kamiya H; Kamidani S; Saitoh A
    Pediatr Infect Dis J; 2023 May; 42(5):e154-e157. PubMed ID: 36795581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of China's compensation program for adverse reactions following immunization.
    Yingxiong W
    Front Public Health; 2023; 11():1211976. PubMed ID: 37608980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations for the development of adult vaccination in China].
    Li L; Xu CS; Liu LJ; Cao L; Song YF; Zhang ZN; Ye JK; Yu WZ; Yin ZD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):2010-2015. PubMed ID: 38186149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluations of immunization programs as an indispensable tool for policymakers.
    den Boon S; Ahmed S; Sarker AR
    BMC Health Serv Res; 2023 Nov; 23(1):1284. PubMed ID: 37993890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishing adult vaccination system to improve the quality of immunization services over the life course].
    Li J; Cao YL; Suo LD; Wu J; Feng LZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):2016-2020. PubMed ID: 38186150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positioning implementation science in national immunization programmes to improve coverage equity and advance progress toward Immunization Agenda 2030: An urgent global health imperative.
    Adamu AA; Ndwandwe D; Jalo RI; Wiysonge CS
    Hum Vaccin Immunother; 2024 Dec; 20(1):2331872. PubMed ID: 38556477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Immunization Program: Computerized System as a tool for new challenges.
    Sato AP
    Rev Saude Publica; 2015; 49():39. PubMed ID: 26176746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.